Using and Sequencing EGFR Exon 20-Targeted Therapies for NSCLC
Xiuning Le, MD, PhD, discusses counseling patients on the use of amivantamab-vmjw and mobocertinib and the sequencing of these drugs for patients with non–small cell lung cancer and an EGFR exon 20 insertion.
Filling in the Treatment Gap for Patients With EGFR+ NSCLC
Xiuning Le, MD, PhD, discusses the limited treatment options available for patients with non–small cell lung cancer and an EGFR exon 20 mutation.
VISION Trial Produces Positive Data in NSCLC With MET Exon 14 Mutations
Xiuning Le, MD, PhD, discusses the results of tepotinib in patients with advanced non-small cell lung cancer and a MET exon 14 skipping mutation.